Literature DB >> 29531100

Use of Asthma APGAR Tools in Primary Care Practices: A Cluster-Randomized Controlled Trial.

Barbara P Yawn1, Peter C Wollan2, Matthew A Rank3, Susan L Bertram2, Young Juhn4, Wilson Pace5.   

Abstract

PURPOSE: The purpose of this study was to assess patient and practice outcomes after introducing the Asthma APGAR (Activities, Persistent, triGGers, Asthma medications, Response to therapy) tools into primary care practices.
METHODS: We used a pragmatic cluster-randomized controlled design in 18 US family medicine and pediatric practices to compare outcomes in patients with persistent asthma aged 5 to 45 years after introduction of the Asthma APGAR tools vs usual care. Patient outcomes included asthma control, quality of life, and emergency department (ED), urgent care, and inpatient hospital visits. The practice outcome was adherence to asthma guidelines.
RESULTS: We enrolled 1,066 patients: 245 children, 174 adolescents, and 647 adults. Sixty-five percent (692 patients) completed both baseline and 12-month questionnaires, allowing analysis for patient-reported outcomes. Electronic health record data were available for 1,063 patients (99.7%) for practice outcomes. The proportion of patients reporting an asthma-related ED, urgent care, or hospital visit in the final 6 months of the study was lower in the APGAR practices vs usual care practices (10.6% vs 20.9%, P = .004). The percentage of patients with "in control" asthma increased more between baseline and 1 year in the APGAR group vs usual care group (13.5% vs 3.4%, P =.0001 vs P =.86) with a trend toward better control scores and asthma-related quality of life in the former at 1 year (P ≤.06 and P = .06, respectively). APGAR practices improved their adherence to 3 or more guideline elements compared with usual care practices (20.7% increase vs 1.9% decrease, P = .001).
CONCLUSIONS: Introduction of the Asthma APGAR tools improves rates of asthma control; reduces asthma-related ED, urgent care, and hospital visits; and increases practices' adherence to asthma management guidelines.
© 2018 Annals of Family Medicine, Inc.

Entities:  

Keywords:  asthma; asthma control; asthma management; asthma tool; guideline; implementation; outcomes; practice-based research; pragmatic research; primary care; protocol; randomized clinical trial

Mesh:

Year:  2018        PMID: 29531100      PMCID: PMC5847347          DOI: 10.1370/afm.2179

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  71 in total

1.  Assessment of asthma control and severity.

Authors:  William M Vollmer
Journal:  Ann Allergy Asthma Immunol       Date:  2004-11       Impact factor: 6.347

2.  Interrater reliability: completing the methods description in medical records review studies.

Authors:  Barbara P Yawn; Peter Wollan
Journal:  Am J Epidemiol       Date:  2005-05-15       Impact factor: 4.897

3.  Encouraging innovation, unintended consequences, and group-level research.

Authors:  Robert L Williams; Kurt Stange; William R Phillips; Louise S Acheson; Bijal Balasubramanian; Elizabeth A Bayliss; Robert L Ferrer; James M Gill
Journal:  Ann Fam Med       Date:  2013 May-Jun       Impact factor: 5.166

4.  The Agency for Healthcare Research and Quality (AHRQ) Practice-Based Research Network (PBRN) relationship: delivering on an opportunity, challenges, and future directions.

Authors:  Wilson D Pace; L J Fagnan; David R West
Journal:  J Am Board Fam Med       Date:  2011 Sep-Oct       Impact factor: 2.657

5.  A quality improvement study using fishbone analysis and an electronic medical records intervention to improve care for children with asthma.

Authors:  Jonathan Gold; David Reyes-Gastelum; Jane Turner; H Dele Davies
Journal:  Am J Med Qual       Date:  2013-04-09       Impact factor: 1.852

6.  Asking the correct questions to assess asthma symptoms.

Authors:  Michael D Cabana; Kathryn K Slish; Bin Nan; Xihong Lin; Noreen M Clark
Journal:  Clin Pediatr (Phila)       Date:  2005-05       Impact factor: 1.168

7.  Association of asthma control with health care utilization: a prospective evaluation.

Authors:  William M Vollmer; Leona E Markson; Elizabeth O'Connor; E Ann Frazier; Marc Berger; A Sonia Buist
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

8.  Patient factors that physicians use to assign asthma treatment.

Authors:  Gregory B Diette; Cecilia M Patino; Barry Merriman; Laura Paulin; Kristin Riekert; Sande Okelo; Kathy Thompson; Jerry A Krishnan; Ruth Quartey; Deanna Perez-Williams; Cynthia Rand
Journal:  Arch Intern Med       Date:  2007-07-09

9.  Asthma treatment in a population-based cohort: putting step-up and step-down treatment changes in context.

Authors:  Barbara P Yawn; Peter C Wollan; Susan L Bertram; David Lowe; Joseph H Butterfield; Denise Bonde; James T C Li
Journal:  Mayo Clin Proc       Date:  2007-04       Impact factor: 7.616

10.  Primary Care Pathway for Childhood Asthma: Protocol for a Randomized Cluster-Controlled Trial.

Authors:  Andrew J Cave; Heather Sharpe; Mark Anselmo; A Dean Befus; Gillian Currie; Christina Davey; Neil Drummond; Jim Graham; Lee A Green; Jeremy Grimshaw; Karen Kam; Donna P Manca; Alberto Nettel-Aguirre; Melissa L Potestio; Brian H Rowe; Shannon D Scott; Tyler Williamson; David W Johnson
Journal:  JMIR Res Protoc       Date:  2016-03-08
View more
  3 in total

Review 1.  Is It Time for a Patient-Centered Quality Measure of Asthma Control?

Authors:  Elizabeth Herman; Suzanne Beavers; Ben Hamlin; Kaytna Thaker
Journal:  J Allergy Clin Immunol Pract       Date:  2019-04-04

Review 2.  Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population.

Authors:  Amelia Licari; Ilaria Brambilla; Alessia Marseglia; Maria De Filippo; Valeria Paganelli; Gian L Marseglia
Journal:  Front Pediatr       Date:  2018-06-19       Impact factor: 3.418

3.  Facilitators and barriers to the implementation of the Primary Care Asthma Paediatric Pathway: a qualitative analysis.

Authors:  Heather Sharpe; Melissa Potestio; Andrew Cave; David W Johnson; Shannon D Scott
Journal:  BMJ Open       Date:  2022-05-12       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.